Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).
Phase 1
Completed
- Conditions
- Wilson's Disease
- Interventions
- Drug: 900mg TETA 4HCl Once Daily FormulationDrug: 900mg TETA 4HCl Cuprior®
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Orphalan
- Target Recruit Count
- 24
- Registration Number
- NCT06128954
- Locations
- 🇬🇧
Richmond Pharmacology Ltd, London, United Kingdom
Real World Evidence Study in Subjects With Wilson's Disease
Active, not recruiting
- Conditions
- Wilson Disease
- Interventions
- Diagnostic Test: NCC-Sp Assay
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Orphalan
- Target Recruit Count
- 50
- Registration Number
- NCT05783687
- Locations
- 🇺🇸
John Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Vanderbilt University Medical Centre, Nashville, Tennessee, United States
🇺🇸Northwestern University Chicago (Hepatologist), Chicago, Illinois, United States
International Wilson's Disease Patient Registry (iWilson Registry)
Recruiting
- Conditions
- Wilson's Disease
- First Posted Date
- 2022-02-15
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Orphalan
- Target Recruit Count
- 500
- Registration Number
- NCT05239858
- Locations
- 🇵🇱
Institute of Psychiatry and Neurology, Warsaw, Poland
🇧🇪University Hospital Leuven, Leuven, Belgium
🇵🇱The Children's Memorial Health Institute, Warsaw, Poland
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
Phase 3
Completed
- Conditions
- Wilson Disease
- Interventions
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Orphalan
- Target Recruit Count
- 77
- Registration Number
- NCT03539952
- Locations
- 🇧🇷
Nucleo de Pesquisa e Desenvolvimento de Medicamentos - Universidade Federal do Ceará - Rodolfo Teófilo, Fortaleza, Brazil
🇮🇹DiSCOG Gastroenterology Unit, Padova, Italy
🇫🇷Centre National de Référence Wilson, Hôpital Lariboisière, Paris, France
© Copyright 2025. All Rights Reserved by MedPath